Notably, immunohistochemical staining of CD3+ cells in tumor tissues revealed a substantial number of CD3+ T cells in the tumor sections of OCT4-3 + TLR9-treated mice, suggesting that T cells were likely effector cells mediating tumor regression (Figure 4A). This evidence concerns the gene TLR9 and neoplasm.